Suche
Mein Konto
Microcarrier market is booming: USD 3.05 billion expected by 2029!
Eppendorf SE, a key player in the microcarrier market, benefits from growing demand for biopharmaceuticals and cell therapies.
Microcarrier market is booming: USD 3.05 billion expected by 2029!
The market for microcarriers is booming and shows enormous growth potential. Like that The Globe and Mail Reported, the market was valued at about $2.03 billion in 2023 and is expected to grow to $3.05 billion by 2029. This corresponds to an annual growth rate (CAGR) of 8.0%. This growth is driven in particular by investments in research into cell and gene therapies as well as an increasing preference for single-use technologies.
The consumables segment plays a pivotal role as it involves repeat purchases and massive requirements. Biopharmaceutical production in particular, including the production of vaccines and cell and gene therapies, is more in demand than ever. Numerous companies, including giants such as Thermo Fisher Scientific, Danaher and Merck KGaA, are active here to meet the increased requirements.
Market overview and key players
The leading companies in the microcarrier market include Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA and GE Healthcare. These companies not only have a strong product portfolio, but are also continually expanding their production capacities to meet increased demands. Thermo Fisher recently introduced new products to optimize cell culture.
Another company that stands out in the microcarrier market is Pricella, which offers complete growing media that contain various nutrients and have undergone rigorous testing to ensure the highest quality. Their goal is to offer a comprehensive range of more than 1,400 products specifically optimized for a variety of cell types.
Growth factors and challenges
A key driving force behind the growth of the microcarrier market is the increasing need for vaccines, especially in view of the global health situation. The increase in cancer cases and chronic diseases is also having a significant impact as medicine increasingly pursues regenerative approaches. According to WCRF International, there were approximately 18.1 million newly diagnosed cases of cancer worldwide in 2020.
But there are also challenges. High costs in cell biology and the limitations of high-density cell culture production represent hurdles that must be overcome. This could be particularly challenging for small and medium-sized companies in the sector as they have to compete against large players.
Overall, the microcarrier market is a dynamic and exciting environment. The willingness to invest, coupled with the necessary technological advances, will further boost the industry in the coming years. As the market moves into a new dimension, both opportunities and challenges remain.